StonvexLoading…
StonvexStonvexStonvexCore line items from HNI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $1.35B | $2.84B | $1.95B | $1.27B |
Operating Income | $-36.40M | $126.00M | $157.20M | $92.60M |
Net Income | $-38.80M | $54.20M | $103.40M | $62.20M |
EPS (Diluted) | $-0.55 | $1.11 | $2.19 | $1.31 |
Total Assets | $4.77B | $4.88B | $1.84B | $1.91B |
Total Liabilities | $3.00B | $3.05B | $1.01B | $1.10B |
Cash & Equivalents | $71.40M | $209.20M | $20.70M | $32.00M |
Free Cash Flow OCF − CapEx | $-207.50M | $208.50M | $148.10M | $12.50M |
Shares Outstanding | 71.60M | 71.30M | 47.30M | 47.60M |